Robert W. Baird Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $115.00
Zimmer Biomet (NYSE:ZBH – Free Report) had its price target trimmed by Robert W. Baird from $130.00 to $115.00 in a research report sent to investors on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the medical equipment provider’s stock. A number of other analysts also recently issued reports on the company. BTIG […]
Zimmer Biomet (NYSE:ZBH – Free Report) had its price target trimmed by Robert W. Baird from $130.00 to $115.00 in a research report sent to investors on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the medical equipment provider’s stock. A number of other analysts also recently issued reports on the company. BTIG […]
